Finally, our results found that silencing LINC01644 and LINC01697 inhibited the proliferation of GC cells, suggesting that LINC01644 and LINC01697 contribute to the pathogenesis and progression of GC as therapeutic targeting. Here, LINC01644 is linked to gastric cancer.